Abstract BCL-2 inhibitors such as venetoclax offer therapeutic promise in acute myeloid leukemia (AML) and other cancers. but drug resistance poses a significant challenge. It is crucial to understand the mechanisms that regulate venetoclax response. While correlative studies have identified numerous genes linked to venetoclax sensitivity. https://www.chiggate.com/turbo-air-m3f72-3-n-78-wide-m3-series-reach-in-freezer-featuring-three-solid-doors-energy-star-online-now/